Latest Headlines
-
Shapiro Administration Invests Nearly $3 Million To Bring Adare Pharma Solutions' Headquarters To Pennsylvania, Creating 115 New, Well-Paying Jobs In Philadelphia
8/5/2024
The life sciences company is investing at least $16.8 million to relocate its headquarters to PA from New Jersey and upgrade its two current Philadelphia facilities, building on Pennsylvania’s reputation as a life sciences leader.
-
AGC Biologics' Seattle Site Achieves Successful Multi-Product Inspection By U.S. Food And Drug Administration For Biologics License Applications
8/1/2024
CDMO site shares promising outcomes after in Q1 2024 FDA inspections and is now producing two new products for commercial usage in the U.S.
-
What To Do With Unexpected Positive Biological Indicator Results" Webinar Announced
8/1/2024
The webinar on "What to do with Unexpected Positive Biological Indicator (BI) Results" seems like a valuable opportunity for those dealing with disruptions in sterilization processes.
-
CordenPharma Invests €900m In Transformational Peptide Platform Expansion In The USA & Europe
7/16/2024
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technology platform. These transformational plans consist of two major expansion initiatives occurring in parallel in the US and Europe, including both existing facilities and new constructions designed and built according to the pharmaceutical industry’s most stringent quality and technical standards for short and long peptide manufacturing, including Biologics License Applications (BLA) requirements.
-
A&E Firm Jacobs Selected To Support Fujifilm Diosynth Biotechnologies Large-Scale Cell Culture Manufacturing Facility
6/28/2024
Jacobs (NYSE:J) was selected by FUJIFILM Diosynth Biotechnologies to support delivery of $1.2 billion expansion of an end-to-end, large-scale cell culture contract manufacturing site in Holly Springs, North Carolina. Jacobs was originally selected to support the construction for the FUJIFILM Diosynth Biotechnologies' Holly Springs site, which broke ground in 2021. Jacobs will provide engineering, procurement and construction management services for the site's latest expansion.
-
CAI Announces, 'How Can Drug Manufacturing Utilize Technology To Improve Efficiency And Reduce Waste' Event In Indianapolis July 25th
6/27/2024
Join CAI on Thursday, July 25th in Indy for dinner, drinks and discussion with industry experts.
-
Abzena And Argonaut Partner To Offer Accelerated End-To-End Drug Development Support For Biopharmaceutical Companies
6/20/2024
Biopharma gains a seamless transition from drug discovery through drug product manufacturing.
-
Driving Innovation And Performance While Reducing Cost Of Goods In Drug Production
6/17/2024
Renato Azevedo, Purolite’s Senior Director of Product Management, shares insight into the latest innovation in Purolite’s resin toolbox: DurA Cycle.
-
Kyowa Kirin Announces Plans To Build New Biologics Manufacturing Facility In Sanford, NC
6/10/2024
Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin) (TSE: 4151), a global specialty pharmaceutical company based in Japan, today announced that its board of directors has approved plans to invest up to $530 million to build a new, state-of-the-art manufacturing facility in Sanford, North Carolina.
-
Webinar: Leveraging Digital Solutions For Regulatory Compliance In Biomanufacturing
6/6/2024
Join Honeywell to learn more from Dr. Arshad Azwad on how biomanufacturing companies are leveraging digital systems to navigate regulatory challenges.